T1	CHEM 32 45	pentobarbital
#1	AnnotatorNotes T1	C0030883; pentobarbital; Organic Chemical · Pharmacologic Substance
T2	CHEM 51 60	tiopental
#2	AnnotatorNotes T2	C0039925; thiopental; Organic Chemical · Pharmacologic Substance
T3	PROC 67 106	control de la hipertensión intracraneal
T4	DISO 81 106	hipertensión intracraneal
#3	AnnotatorNotes T4	C0151740; Intracranial Hypertension; Finding
T5	CHEM 210 223	pentobarbital
#4	AnnotatorNotes T5	C0030883; pentobarbital; Organic Chemical · Pharmacologic Substance
T6	CHEM 226 235	tiopental
#5	AnnotatorNotes T6	C0039925; thiopental; Organic Chemical · Pharmacologic Substance
T7	PROC 242 281	control de la hipertensión intracraneal
T8	PROC 1631 1649	se controló la PIC
#6	AnnotatorNotes T8	C0394279; Procedure for monitoring intracranial pressure; Therapeutic or Preventive Procedure (?)
T9	DISO 283 286	HIC
#7	AnnotatorNotes T9	C0151740; Intracranial Hypertension; Finding
T10	PROC 835 838	PIC
#8	AnnotatorNotes T10	C0394279; Procedure for monitoring intracranial pressure; Therapeutic or Preventive Procedure (?)
T11	PROC 306 329	medidas de primer nivel
T12	DISO 417 445	traumatismo craneoencefálico
#9	AnnotatorNotes T12	C0018674; Craniocerebral Trauma; Injury or Poisoning | C0876926; Traumatic Brain Injury; Injury or Poisoning
T13	PROC 481 566	Estudio prospectivo de cohorte, aleatorizado, de intervención terapéutica comparativa
#10	AnnotatorNotes T13	C1709709; Prospective Cohort Study; Research Activity + C0034656; Randomization; Research Activity + C3274035; Interventional Study; Research Activity + C1579762; comparative study research; Research Activity
T14	PROC 1 27	Comparación de la eficacia
#11	AnnotatorNotes T14	C1707887; Efficacy Study; Research Activity
T15	CHEM 577 585	fármacos
#12	AnnotatorNotes T15	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T16	CHEM 587 600	pentobarbital
#13	AnnotatorNotes T16	C0030883; pentobarbital; Organic Chemical · Pharmacologic Substance
T17	CHEM 603 612	tiopental
#14	AnnotatorNotes T17	C0039925; thiopental; Organic Chemical · Pharmacologic Substance
T18	DISO 685 688	TCE
#15	AnnotatorNotes T18	C0018674; Craniocerebral Trauma; Injury or Poisoning | C0876926; Traumatic Brain Injury; Injury or Poisoning
T19	PROC 696 714	Glasgow Coma Scale
#16	AnnotatorNotes T19	C0278349; Glasgow coma testing and evaluation; Laboratory Procedure
T20	DISO 751 772	deterioro neurológico
#17	AnnotatorNotes T20	C1536136; Neurological status deterioration; Sign or Symptom | C5563390; Deterioration of neurologic status; Finding
T21	DISO 799 810	traumatismo
#18	AnnotatorNotes T21	C3263723; Traumatic injury; Injury or Poisoning | C3714660; Trauma; Injury or Poisoning
T22	DISO 830 833	HIC
#19	AnnotatorNotes T22	C0151740; Intracranial Hypertension; Finding
T23	PROC 864 888	tratamiento convencional
#20	AnnotatorNotes T23	C2945704; Conventional Treatment; Therapeutic or Preventive Procedure
T24	PROC 1422 1425	GCS
#21	AnnotatorNotes T24	C0278349; Glasgow coma testing and evaluation; Laboratory Procedure
T25	PROC 1006 1023	control de la PIC
#22	AnnotatorNotes T25	C0394279; Procedure for monitoring intracranial pressure; Therapeutic or Preventive Procedure (?)
T26	DISO 1051 1086	efectos secundarios del tratamiento
#23	AnnotatorNotes T26	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T27	PROC 1075 1086	tratamiento
#24	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	CHEM 1201 1210	tiopental
#25	AnnotatorNotes T28	C0039925; thiopental; Organic Chemical · Pharmacologic Substance
T29	CHEM 1218 1231	pentobarbital
#26	AnnotatorNotes T29	C0030883; pentobarbital; Organic Chemical · Pharmacologic Substance
T30	DISO 1368 1382	comorbilidades
#27	AnnotatorNotes T30	C1275743; Co-morbid conditions; Finding
T31	PROC 1429 1436	ingreso
#28	AnnotatorNotes T31	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T32	CHEM 1438 1447	tiopental
#29	AnnotatorNotes T32	C0039925; thiopental; Organic Chemical · Pharmacologic Substance
T33	CHEM 1461 1474	pentobarbital
#30	AnnotatorNotes T33	C0030883; pentobarbital; Organic Chemical · Pharmacologic Substance
T34	PROC 1506 1538	tomografía craneal computarizada
#31	AnnotatorNotes T34	C0412585; CAT scan of brain; Diagnostic Procedure (?)
T35	PROC 1542 1549	ingreso
#32	AnnotatorNotes T35	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T36	DISO 256 281	hipertensión intracraneal
#33	AnnotatorNotes T36	C0151740; Intracranial Hypertension; Finding
T37	CHEM 1621 1630	tiopental
#34	AnnotatorNotes T37	C0039925; thiopental; Organic Chemical · Pharmacologic Substance
T38	PROC 2129 2152	medidas de primer nivel
T39	CHEM 1682 1695	pentobarbital
#35	AnnotatorNotes T39	C0030883; pentobarbital; Organic Chemical · Pharmacologic Substance
T40	CHEM 1752 1761	tiopental
#36	AnnotatorNotes T40	C0039925; thiopental; Organic Chemical · Pharmacologic Substance
T41	CHEM 1796 1809	pentobarbital
#37	AnnotatorNotes T41	C0030883; pentobarbital; Organic Chemical · Pharmacologic Substance
T42	DISO 1902 1922	hipotensión arterial
#38	AnnotatorNotes T42	C0020649; Hypotension; Finding
T43	DISO 1931 1957	complicaciones infecciosas
#39	AnnotatorNotes T43	C0940933; infection as a complication; Disease or Syndrome
T44	PROC 1739 1747	tratados
#40	AnnotatorNotes T44	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T45	DISO 447 450	TCE
#41	AnnotatorNotes T45	C0018674; Craniocerebral Trauma; Injury or Poisoning | C0876926; Traumatic Brain Injury; Injury or Poisoning
T46	PROC 715 718	GCS
#42	AnnotatorNotes T46	C0278349; Glasgow coma testing and evaluation; Laboratory Procedure
T47	CHEM 2034 2043	tiopental
#43	AnnotatorNotes T47	C0039925; thiopental; Organic Chemical · Pharmacologic Substance
T48	CHEM 2073 2086	pentobarbital
#44	AnnotatorNotes T48	C0030883; pentobarbital; Organic Chemical · Pharmacologic Substance
T49	PROC 2093 2110	control de la HIC
T50	DISO 2107 2110	HIC
#45	AnnotatorNotes T50	C0151740; Intracranial Hypertension; Finding
T51	PROC 978 999	comprobar la eficacia
#46	AnnotatorNotes T51	C1707887; Efficacy Study; Research Activity
T52	CHEM 2264 2272	fármacos
#47	AnnotatorNotes T52	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T53	CHEM 2408 2416	fármacos
#48	AnnotatorNotes T53	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T54	ANAT 94 106	intracraneal
#49	AnnotatorNotes T54	C0524466; Intracranial; Body Location or Region
T55	ANAT 269 281	intracraneal
#50	AnnotatorNotes T55	C0524466; Intracranial; Body Location or Region
T56	DISO 1762 1773	fallecieron
#51	AnnotatorNotes T56	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T57	ANAT 1914 1922	arterial
#52	AnnotatorNotes T57	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T58	PROC 185 205	Comparar la eficacia
#53	AnnotatorNotes T58	C1707887; Efficacy Study; Research Activity
T59	LIVB 163 172	pacientes
#54	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T61	LIVB 403 412	pacientes
#55	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group
T62	LIVB 658 667	pacientes
#56	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	Duration 776 793	la primera semana
T65	LIVB 1149 1158	pacientes
#57	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T67	LIVB 1323 1332	pacientes
#58	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T70	LIVB 1703 1712	pacientes
#59	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T71	LIVB 1729 1738	pacientes
#60	AnnotatorNotes T71	C0030705; Patients; Patient or Disabled Group
T75	LIVB 504 511	cohorte
#61	AnnotatorNotes T75	C0599755; Cohort; Population Group
T60	Time 720 736	postresucitación
T64	PROC 1159 1169	reclutados
#62	AnnotatorNotes T64	C0242800; Patient Recruitment; Research Activity
R1	Used_for Arg1:T2 Arg2:T3	
R2	Used_for Arg1:T1 Arg2:T3	
R3	Location_of Arg1:T54 Arg2:T4	
R4	Location_of Arg1:T54 Arg2:T3	
R5	Experiences Arg1:T59 Arg2:T4	
R6	Experiences Arg1:T59 Arg2:T3	
R9	Location_of Arg1:T55 Arg2:T36	
R10	Location_of Arg1:T55 Arg2:T9	
R11	Location_of Arg1:T55 Arg2:T7	
R12	Experiences Arg1:T61 Arg2:T12	
R13	Experiences Arg1:T61 Arg2:T45	
R14	Experiences Arg1:T61 Arg2:T9	
R15	Experiences Arg1:T61 Arg2:T36	
R16	Experiences Arg1:T61 Arg2:T5	
R19	Causes Arg1:T12 Arg2:T9	
R20	Causes Arg1:T12 Arg2:T36	
R21	Causes Arg1:T45 Arg2:T9	
R22	Causes Arg1:T45 Arg2:T36	
R23	Experiences Arg1:T61 Arg2:T11	
T66	Quantifier_or_Qualifier 288 299	refractaria
#63	AnnotatorNotes T66	C0205269; Unresponsive to Treatment; Functional Concept
T68	Quantifier_or_Qualifier 452 457	grave
R24	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T68	
R25	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T68	
R26	Experiences Arg1:T75 Arg2:T16	
R27	Experiences Arg1:T75 Arg2:T17	
T69	Quantifier_or_Qualifier 689 694	grave
R28	Has_Quantifier_or_Qualifier Arg1:T18 Arg2:T69	
R29	Experiences Arg1:T62 Arg2:T18	
R30	Experiences Arg1:T62 Arg2:T19	
R31	Experiences Arg1:T62 Arg2:T46	
R32	Overlap Arg1:T46 Arg2:T60	
R33	Overlap Arg1:T19 Arg2:T60	
R34	Experiences Arg1:T62 Arg2:T20	
R35	Has_Duration_or_Interval Arg1:T20 Arg2:T63	
R36	After Arg1:T20 Arg2:T21	
R37	Causes Arg1:T18 Arg2:T22	
T72	Quantifier_or_Qualifier 849 860	refractaria
#64	AnnotatorNotes T72	C0205269; Unresponsive to Treatment; Functional Concept
R38	Causes Arg1:T27 Arg2:T26	
R39	Experiences Arg1:T62 Arg2:T22	
R41	Experiences Arg1:T62 Arg2:T23	
R42	Experiences Arg1:T62 Arg2:T10	
R43	Experiences Arg1:T65 Arg2:T64	
R44	Experiences Arg1:T65 Arg2:T28	
R45	Experiences Arg1:T65 Arg2:T29	
T73	Neg_cue 1233 1235	No
T74	CONC 909 934	Guías de Práctica Clínica
#65	AnnotatorNotes T74	C0282451; Clinical Practice Guideline; Intellectual Product
T76	CONC 1241 1252	diferencias
#66	AnnotatorNotes T76	C1705241; Delta (difference); Quantitative Concept
A1	Assertion T76 Negated
R46	Negation Arg1:T73 Arg2:T76	
T77	CONC 1346 1365	índices de gravedad
#67	AnnotatorNotes T77	C3864289; Emergency severity index; Intellectual Product (?)
T78	Neg_cue 1385 1392	Tampoco
T79	CONC 1398 1409	diferencias
A2	Assertion T79 Negated
#68	AnnotatorNotes T79	C1705241; Delta (difference); Quantitative Concept
R47	Negation Arg1:T78 Arg2:T79	
R48	Overlap Arg1:T24 Arg2:T31	
R49	Overlap Arg1:T34 Arg2:T35	
R50	Experiences Arg1:T67 Arg2:T30	
R51	Experiences Arg1:T71 Arg2:T44	
R52	Used_for Arg1:T40 Arg2:T44	
R53	Experiences Arg1:T71 Arg2:T56	
R55	Used_for Arg1:T41 Arg2:T44	
T80	Neg_cue 1820 1822	No
T81	CONC 1828 1839	diferencias
A3	Assertion T81 Negated
#69	AnnotatorNotes T81	C1705241; Delta (difference); Quantitative Concept
R57	Negation Arg1:T80 Arg2:T81	
R58	Location_of Arg1:T57 Arg2:T42	
R60	Experiences Arg1:T70 Arg2:T8	
R62	Used_for Arg1:T37 Arg2:T8	
R63	Used_for Arg1:T39 Arg2:T8	
T82	Quantifier_or_Qualifier 2055 2065	más eficaz
R59	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T82	
R61	Used_for Arg1:T47 Arg2:T49	
R64	Used_for Arg1:T48 Arg2:T49	
T83	Quantifier_or_Qualifier 2111 2122	refractaria
#70	AnnotatorNotes T83	C0205269; Unresponsive to Treatment; Functional Concept
R65	Has_Quantifier_or_Qualifier Arg1:T50 Arg2:T83	
R66	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T66	
R67	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T66	
R40	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T72	
R68	Before Arg1:T11 Arg2:T6	
R69	Before Arg1:T11 Arg2:T5	
R71	Before Arg1:T38 Arg2:T48	
T84	Quantifier_or_Qualifier 107 118	refractaria
#71	AnnotatorNotes T84	C0205269; Unresponsive to Treatment; Functional Concept
R72	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T84	
R7	Used_for Arg1:T6 Arg2:T7	
R8	Used_for Arg1:T5 Arg2:T7	
R70	Before Arg1:T38 Arg2:T47	
T85	CONC 341 366	Guías de Práctica Clínica
#72	AnnotatorNotes T85	C0282451; Clinical Practice Guideline; Intellectual Product
T86	Result_or_Value 739 748	≤8 puntos
R76	Has_Result_or_Value Arg1:T46 Arg2:T86	
R77	Has_Result_or_Value Arg1:T19 Arg2:T86	
T87	Result_or_Value 839 847	>20 mmHg
R78	Has_Result_or_Value Arg1:T10 Arg2:T87	
R75	Experiences Arg1:T70 Arg2:T39	
R79	Experiences Arg1:T70 Arg2:T37	
R80	Experiences Arg1:T71 Arg2:T41	
T88	Spec_cue 2044 2050	podría
R81	Speculation Arg1:T88 Arg2:T82	
A4	Assertion T82 Speculated
T89	CONC 1292 1315	características basales
#73	AnnotatorNotes T89	C4684572; Baseline Characteristics; Qualitative Concept
T90	Quantifier_or_Qualifier 1840 1854	significativas
A5	Assertion T90 Negated
#74	AnnotatorNotes T90	C0237881; Statistical Significance; Quantitative Concept
R82	Has_Quantifier_or_Qualifier Arg1:T81 Arg2:T90	
R83	Negation Arg1:T80 Arg2:T90	
T91	Quantifier_or_Qualifier 1253 1284	estadísticamente significativas
A6	Assertion T91 Negated
#75	AnnotatorNotes T91	C0237881; Statistical Significance; Quantitative Concept
R84	Has_Quantifier_or_Qualifier Arg1:T76 Arg2:T91	
R85	Negation Arg1:T73 Arg2:T91	
R86	Experiences Arg1:T61 Arg2:T6	
#76	AnnotatorNotes T68	C1547227; Severe - Severity of Illness Code; Intellectual Product
#77	AnnotatorNotes T69	C1547227; Severe - Severity of Illness Code; Intellectual Product
A7	Experiencer T59 Patient
A8	Experiencer T61 Patient
A9	Experiencer T75 Patient
A10	Experiencer T62 Patient
A11	Experiencer T65 Patient
A12	Experiencer T67 Patient
A13	Experiencer T70 Patient
A14	Experiencer T71 Patient
